Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative

Farah Ramadan1,2,3,4, Raya Saab5,6,7, Farah Ghamloush5

  • 1Université Lyon 1, Lyon, France.

Cancers
|May 11, 2024
PubMed

Insights

Exosomal miR-1246 from fusion-negative rhabdomyosarcoma (FN-RMS) promotes cancer cell aggressiveness. Targeting this microRNA may offer new therapeutic strategies for pediatric rhabdomyosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Rhabdomyosarcoma (RMS) is a pediatric cancer characterized by aggressiveness and metastasis.
  • Fusion-negative RMS (FN-RMS) is the most common subtype, with metastasis significantly impacting survival.
  • Exosomes from RMS cells contain microRNAs (miRNAs), including miR-1246, potentially driving disease aggressiveness.

Purpose of the Study:

  • To investigate the functional role of exosomal miR-1246 in promoting FN-RMS aggressiveness.
  • To determine the impact of exosomal miR-1246 on recipient cell behavior and underlying molecular mechanisms.
  • To assess the clinical relevance of exosomal miR-1246 levels in rhabdomyosarcoma patients.

Main Methods:

  • Treatment of normal fibroblasts with FN-RMS-derived exosomes and miR-1246 mimics.
  • Silencing miR-1246 in FN-RMS cells and analyzing the effects of derived exosomes.
  • Investigating the molecular targets of exosomal miR-1246, including GSK3β and the Wnt pathway.
  • Analyzing serum samples from RMS patients for exosomal miR-1246 levels.

Main Results:

  • FN-RMS exosomes carrying miR-1246 significantly increased fibroblast proliferation, migration, and invasion.
  • Delivery of miR-1246 mimics replicated these pro-aggressive effects.
  • Silencing miR-1246 in FN-RMS cells reversed the pro-metastatic effects of their exosomes.
  • Exosomal miR-1246 was found to target GSK3β, promoting Wnt pathway activation.
  • Elevated exosomal miR-1246 levels were detected in RMS patients' sera.

Conclusions:

  • Exosomal miR-1246 actively promotes FN-RMS aggressiveness by altering the tumor microenvironment.
  • miR-1246 influences recipient cell behavior through GSK3β targeting and Wnt pathway deregulation.
  • Exosomal miR-1246 represents a potential biomarker and therapeutic target for rhabdomyosarcoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K